STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

FOXO Technologies (NASDAQ: FOXO) subsidiary Myrtle Recovery Centers earns RHA Tennessee recognition

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

FOXO Technologies Inc. reported that its behavioral health subsidiary, Myrtle Recovery Centers, was honored by the Rural Health Association of Tennessee at the RHA Annual Conference Awards Luncheon on December 9, 2025. The recognition highlights Myrtle Recovery Centers’ role in behavioral health services within rural communities.

The company shared this news through a press release, which is included as Exhibit 99.1. FOXO stated that the information is being furnished under Regulation FD and is not deemed filed for liability purposes under the Exchange Act or automatically incorporated into other securities filings.

Positive

  • None.

Negative

  • None.
false 0001812360 0001812360 2025-12-09 2025-12-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date Earliest Event Reported): December 9, 2025

 

FOXO TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39783   85-1050265

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

477 South Rosemary Avenue
Suite 224
West Palm Beach, FL
  33401
(Address of Principal Executive Offices)   (Zip Code)

 

(612) 800-0059

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A        

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 7.01 Regulation FD Disclosure.

 

On December 9, 2025, FOXO Technologies Inc., a Delaware corporation (the “Company”), issued a press release which announced that its behavioral health subsidiary, Myrtle Recovery Centers, was recognized by the Rural Health Association of Tennessee (RHA) at the RHA Annual Conference Awards Luncheon on December 9, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

The information under this Item 7.01, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibit hereto, is material or that the dissemination of such information is required by Regulation FD.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains “forward-looking statements.” Any statements contained in this Current Report on Form 8-K that do not describe historical facts may constitute forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “if,” “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These forward-looking statements are based on information currently available to the Company’s management as well as estimates and assumptions made by its management and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause the Company’s or its industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. These forward-looking statements are made as of the date of this Current Report on Form 8-K, and the Company does not undertake an obligation to update these forward-looking statements after such date.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

Number

  Description of Exhibit
99.1   Press Release Dated December 9, 2025
104   Cover Page Interactive Data File (formatted in Inline XBRL)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  FOXO Technologies Inc.
     
Date: December 10, 2025 By: /s/ Seamus Lagan
  Name: Seamus Lagan
  Title: Chief Executive Officer

 

3

 

FAQ

What did FOXO Technologies Inc. (FOXO) announce in this 8-K filing?

FOXO Technologies Inc. announced that its behavioral health subsidiary, Myrtle Recovery Centers, was recognized by the Rural Health Association of Tennessee at the RHA Annual Conference Awards Luncheon on December 9, 2025.

Who recognized Myrtle Recovery Centers, the FOXO (FOXO) subsidiary?

Myrtle Recovery Centers was recognized by the Rural Health Association of Tennessee at its Annual Conference Awards Luncheon.

What subsidiary of FOXO Technologies Inc. (FOXO) is mentioned in the filing?

The filing highlights FOXO’s behavioral health subsidiary, Myrtle Recovery Centers.

How did FOXO (FOXO) communicate this recognition to the public?

FOXO communicated the recognition through a press release dated December 9, 2025, which is attached as Exhibit 99.1 to the report.

Is the information in this FOXO (FOXO) 8-K considered filed under the Exchange Act?

No. FOXO states that the information furnished under Item 7.01, including Exhibit 99.1, is being furnished, not filed, and is not subject to Section 18 liabilities or incorporated into other filings except by specific reference.

Does FOXO Technologies Inc. (FOXO) include any forward-looking statements in this report?

Yes. The company notes that the report contains forward-looking statements, identifies typical forward-looking terminology, and explains that such statements are subject to risks and uncertainties and are made as of the date of the report.

What exhibits are included with this FOXO (FOXO) 8-K?

The report lists Exhibit 99.1, a press release dated December 9, 2025, and Exhibit 104, the cover page interactive data file formatted in Inline XBRL.
FOXO TECHNOLOGIES

OTC:FOXO

FOXO Rankings

FOXO Latest News

FOXO Latest SEC Filings

FOXO Stock Data

1.04M
76.60M
0.21%
0.25%
4.32%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States
WEST PALM BEACH